Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Kotak Mahindra Bank Shares In Focus: Brokerages Stay Bullish On 'Surprise' CEO Exit - Should You Buy?
CLSA, Jefferies, Morgan Stanley and Citi reiterated their positive ratings on Kotak Mahindra Bank after the lender announced its CEO transition.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty hints at muted start: Kotak Bank in focus
Sensex Today | Stock Market LIVE Updates: For the Nifty, Tuesday will be the monthly expiry of its contracts as well. Even as the bulls are managing to hold 24,000, there is no conviction at higher levels. Last Thursday's high of 24,261 will be key to watch, while lower levels of 24,000 - 23,800 remain the same.
Kotak Mahindra Bank shares in focus on CEO transition; Here's why Nomura still says 'buy'
In a note on Monday, Nomura said that the CEO transition is unlikely to alter Kotak Mahindra Bank's strategic direction. Therefore, it maintained its "buy" rating on the lender with a price target of ₹460.
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent Systems
Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving averages, with a decisive close above 24,200 crucial for further gains. Several companies like Waaree Energies, Kotak Bank, and Tata Motors are in focus due to significant developments, including US investigations, strategic partnerships, and EV expansion plans.
Stocks to Watch for June 29: HDFC Bank, Kotak Mahindra Bank, Dr Reddy’s and more
After an extended weekend, Dalal Street returns to a packed corporate news flow. From IRFC's successful OFS and Power Grid's fundraising plans to fresh developments at HDFC Bank, KEC International, Aurobindo Pharma and Bajaj Healthcare, here are the stocks likely to remain in focus on Monday.
Broader market winners! How investors found 15 multibaggers in a muted Nifty year?
Despite a subdued Nifty, several Indian stocks have surged, becoming multibaggers for investors. This outperformance is attributed to resilient corporate earnings, particularly in small and mid-cap segments, and company-specific growth drivers. While near-term challenges like rising costs and potential earnings downgrades exist, the overall FY27 outlook remains manageable, with easing geopolitical tensions expected to aid recovery. Investors are advised to focus on fundamentals over momentum.
Nifty Outlook for June 25: Recovery rally puts 24,200 hurdle in focus
Although the index remains hesitant around the 24,100-24,150 zone, the sharp rebound from Tuesday's decline highlights strong buying interest at lower levels, analysts say.
Will Nifty hit 25,000 this month? Key levels to watch in the week ahead
Nifty eyes a potential up move, with immediate targets at 24,300–24,600, though a dash to 25,000 this month appears uncertain. The IT index remains technically weak, while the defence index shows strong momentum, hitting a 52-week high. Experts recommend buying Radico Khaitan and Redington, citing bullish continuation setups and recovery signs respectively.
NLC India shares in focus as government's Offer For Sale opens for non-retail investors
Among the public shareholders, mutual funds of India had a 9.49% stake in NLC India, led mainly by Nippon Life India AMC (5.65%) and Kotak Mahindra MF (2.6%). The stock is up over 30% so far in 2026.
Two Adani Group stocks in focus as GQG sells stake in Rs 5,750 crore deal; SBI MF lone buyer
Adani Enterprises and Adani Energy Solutions will be in focus after GQG Partners sold stakes worth about Rs 5,750 crore via block deals, with SBI Mutual Fund buying the shares. The move is seen as portfolio rebalancing following a strong recovery in Adani Group stocks over the past year.
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal
Shares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece on Tuesday. Promoter-linked entities offloaded their stake, while domestic mutual funds and foreign institutional investors emerged as key buyers, signalling strong institutional participation. The company also launched semaglutide pre-filled syringes in India.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty extends losses to 200 points; Lenskart in focus
Sensex Today | Stock Market LIVE Updates: The bulls may take comfort from the fact that all recent selling has seen a reversal around this 23,250 - 23,350 range. A break of that level risks further downside for the index. Same is the case with the Nifty Bank, which had another 1,000-point range trading day on Monday.